Functional compensation of the low platelet count by increased individual platelet size in a patient with May-Hegglin anomaly presenting with acute myocardial infarction

International Journal of Cardiology

Volumn 64, Issue 2, 1998, Pages 171-177

  Goto, Shinya ^a   Kasahara, Hirofumi ^a   Sakai, Hiroyuki ^a   Goto, Mami ^a   Miyuki Ono, ^a   Ikeda, Yasuo ^b   Jorquera, Juan I ^c   Bravo, M Isabel ^c   Shunnosuke Handa, ^a  

^a TOKAI UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Instituto Grifols   (Spain)

Author keywords

May Hegglin anomaly; Myocardial infarction; Platelets

Indexed keywords

FIBRINOGEN RECEPTOR; VON WILLEBRAND FACTOR;

ACUTE HEART INFARCTION; ADULT; ARTERY THROMBOSIS; ARTICLE; BINDING SITE; BLOOD FLOW; CASE REPORT; HEMOSTASIS; HUMAN; HUMAN CELL; MALE; MAY HEGGLIN ANOMALY; PRIORITY JOURNAL; RISK FACTOR; SHEAR STRESS; THROMBOCYTE AGGREGATION; THROMBOCYTE ANOMALY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TRANSLUMINAL CORONARY ANGIOPLASTY;

BLOOD PLATELETS; HEMATOLOGIC DISEASES; HEMORHEOLOGY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBOCYTOPENIA; VON WILLEBRAND FACTOR;

EID: 0032051834     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(98)00043-6     Document Type: Article

References (18)

1. Fuster V., Badimon L., Badimon J.I., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med. 326:1992;242-250.
2. Goto S., Sakai H., Abe S., Ikeda Y., Handa S. Possible role of platelet glycoprotein Ib, IIb-IIIa and their ligand proteins for the onset of reocclusion and restenosis of coronary arteries after angioplasty. J Jpn Coron Assoc. 3:1997;75-81.
3. Ikeda Y., Murata M., Goto S. von Willebrand factor-dependent shear induced platelet aggregation: Basic mechanism and clinical implications. Ann NY Acad Sci. 811:1997;325-336.
4. Moore S., Friedman R.J., Singal D.P., Gauldie J., Blajchman M.A., Roberts R.S. Inhibition of injury induced thromboatherosclerotic lesions by anti-platelet serum in rabbits. Thromb Haemost. 35:1976;70-81.
5. Fuster V., Fass D.N., Kaye M.P., Josa M., Zinsmeister A.R., Bowie E.J. Arteriosclerosis in normal and von Willebrand pigs: long-term prospective study and aortic transplantation study. Circ Res. 51:1982;587-593.
6. Hamilton R.W., Shaikh B.S., Ottie J.N., Storch A.E., Saleem A., White J.G. Platelet function, ultrastructure, and survival in the May-Hegglin anomaly. Am J Clin Pathol. 74:1980;663-668.
7. Ikeda Y., Handa M., Kawano K.et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest. 87:1991;1234-1240.
8. Goto S., Ikeda Y., Murata M.et al. Epinephrine augments von Willebrand factor-dependent shear-induced platelet aggregation. Circulation. 86:1992;1859-1863.
9. Goto S., Salomon D.R., Ikeda Y., Ruggeri Z.M. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem. 270:1995;23352-23361.
10. Jandl JH. Blood, Textbook of Hematology. Boston: Little, Brown and Company, 1987:575-6.
11. Handa M., Titani K., Holland L.Z., Roberts J.R., Ruggeri Z.M. The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. J Biol Chem. 261:1986;12579-12585.
12. Niiya K., Hodson E., Bader R.et al. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation. Blood. 70:1987;475-483.
13. The TH, Feltkamp TEW. Conjugation of fluorescein isothiocyanate to antibodies. 1. Experiments on the condition of conjugation. Immunology 1970;18:865-873.
14. Goto S., Ikeda Y., Saldivar E., Ruggeri Z.M. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest. 161:1998;479-486.
15. Coller B.S., Zarrabi M.H. Platelet membrane studies in the May-Hegglin anomaly. Blood. 58:1981;279-284.
16. Ricci G., Manservigi R., Albonici L., Zavagli G., Cassai E. Evidence for glycoprotein abnormality in platelets from patients with May-Hegglin anomaly. Thromb Haemost. 54:1985;862-865.
17. Mcdunn S., Hartz W. Jr., Ts'ao C., Green D. Coronary thrombosis in a patient with May-Hegglin anomaly. Am J Clin Pathol. 95:1991;715-718.
18. Savage B., Saldivar E. E., Ruggeri Z.M. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 84:1996;289-297.